Open | $6.010 |
Close | $6.100 |
Volume / Avg. | 149.981K / 231.656K |
Day Range | 5.994 - 6.225 |
52 Wk Range | 2.090 - 8.170 |
Market Cap | $158.641M |
P/E Ratio | 7.153 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | % |
Days to Cover | 3.12 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Syros Pharmaceuticals (NASDAQ: SYRS) through any online brokerage.
Other companies in Syros Pharmaceuticals’s space includes: Zura Bio (NASDAQ:ZURA), CytomX Therapeutics (NASDAQ:CTMX), Atossa Therapeutics (NASDAQ:ATOS), GlycoMimetics (NASDAQ:GLYC) and Adicet Bio (NASDAQ:ACET).
The latest price target for Syros Pharmaceuticals (NASDAQ: SYRS) was reported by Piper Sandler on Tuesday, October 3, 2023. The analyst firm set a price target for 7.00 expecting SYRS to rise to within 12 months (a possible 14.75% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Syros Pharmaceuticals (NASDAQ: SYRS) is $6.1 last updated March 18, 2024 at 4:16 PM EDT.
There are no upcoming dividends for Syros Pharmaceuticals.
Syros Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for Syros Pharmaceuticals.
Syros Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.